Arixtra (fondaparinux sodium), the first in a new class of SYNTHETIC antithrombotics

Organon is now launching Arixtra (fondaparinux sodium), the first in a new class of SYNTHETIC antithrombotics.

It's even smaller than the low-molecular weight heparins.

This smaller size allows it to bind more selectively to factor Xa to inhibit thrombin formation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote